Development and Evaluation of a Pilot Nurse Case Management Model to Address Multidrug-Resistant Tuberculosis (MDR-TB) and HIV in South Africa

被引:19
|
作者
Farley, Jason E. [1 ]
Kelly, Ana M. [2 ]
Reiser, Katrina [1 ]
Brown, Maria [1 ]
Kub, Joan [1 ,3 ]
Davis, Jeane G. [1 ]
Walshe, Louise [3 ]
Van der Walt, Martie [4 ]
机构
[1] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21205 USA
[2] Michigan State Univ, Coll Nursing, E Lansing, MI 48824 USA
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[4] MRC, TB Epidemiol & Intervent Res Unit, Pretoria, South Africa
来源
PLOS ONE | 2014年 / 9卷 / 11期
基金
美国国家卫生研究院;
关键词
XDR-TB; GUIDELINES; INFECTION; EPIDEMIC; CARE;
D O I
10.1371/journal.pone.0111702
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Setting: Multidrug-resistant tuberculosis (MDR-TB) unit in KwaZulu-Natal, South Africa. Objective: To develop and evaluate a nurse case management model and intervention using the tenets of the Chronic Care Model to manage treatment for MDR-TB patients with a high prevalence of human immunodeficiency virus (HIV) co-infection. Design: A quasi-experimental pilot programme utilizing a nurse case manager to manage care for 40 hospitalized MDR-TB patients, 70% HIV co-infected, during the intensive phase of MDR-TB treatment. Patients were followed for six months to compare proximal outcomes identified in the model between the pre- and post-intervention period. Results: The greatest percent differences between baseline and six-month MDR-TB proximal outcomes were seen in the following three areas: baseline symptom evaluation on treatment initiation (95% improvement), baseline and monthly laboratory evaluations completed per guidelines (75% improvement), and adverse drug reactions acted upon by medical and/or nursing intervention (75% improvement). Conclusion: Improvements were identified in guideline-based treatment and monitoring of adverse drug reactions following implementation of the nurse case management intervention. Further study is required to determine if the intervention introduced in this model will ultimately result in improvements in final MDR-TB treatment outcomes.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Multidrug-resistant tuberculosis (MDR-TB) and multidrug-resistant HIV (MDR-HIV) syndemic: challenges in resource limited setting
    Francisco, Christian
    Lansang, Mary Ann
    Salvana, Edsel Maurice
    Leyritana, Katerina
    BMJ CASE REPORTS, 2019, 12 (08)
  • [2] Determinants of multidrug-resistant tuberculosis (MDR-TB) in Belarus
    Skrahina, Alena
    Hurevich, Henadz
    Zalutskaya, Aksana
    Sahalchyk, Evgeni
    Astrauko, Andrei
    Hoffner, Sven
    Rusovich, Valiantsin
    Dadu, Andrei
    de Colombani, Pierpaolo
    Dara, Masoud
    Van Gemert, Wayne
    Zignol, Matteo
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [3] Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
    Ali, Monadil H.
    Alrasheedy, Alian A.
    Hassali, Mohamed Azmi
    Kibuule, Dan
    Godman, Brian
    ANTIBIOTICS-BASEL, 2019, 8 (03):
  • [4] The role of the nurse in the community-based treatment of multidrug-resistant tuberculosis (MDR-TB)
    Palacios, E
    Guerra, D
    Llaro, K
    Chalco, K
    Sapag, R
    Furin, J
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2003, 7 (04) : 343 - 346
  • [5] Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment
    Ormerod, LP
    BRITISH MEDICAL BULLETIN, 2005, 73-74 : 17 - 24
  • [6] New Drugs for the Treatment of Multidrug-resistant Tuberculosis (MDR-TB)
    Schaberg, T.
    Otto-Knapp, R.
    Bauer, T.
    PNEUMOLOGIE, 2015, 69 (05): : 282 - 286
  • [7] Multidrug-resistant tuberculosis (MDR-TB) in a BMT recipient.
    Altclas, JD
    Adrian, LO
    Salgueira, CC
    Brennan, VI
    Di Martino, A
    Ritacco, V
    Palmero, D
    BLOOD, 2003, 102 (11) : 445B - 445B
  • [8] Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines
    Satria A. Prabowo
    Matthias I. Gröschel
    Ed D. L. Schmidt
    Alena Skrahina
    Traian Mihaescu
    Serap Hastürk
    Rotislav Mitrofanov
    Edita Pimkina
    Ildikó Visontai
    Bouke de Jong
    John L. Stanford
    Père-Joan Cardona
    Stefan H. E. Kaufmann
    Tjip S. van der Werf
    Medical Microbiology and Immunology, 2013, 202 : 95 - 104
  • [9] Disadvantage and the experience of treatment for multidrug-resistant tuberculosis (MDR-TB)
    Taylor, Holly A.
    Dowdy, David W.
    Searle, Alexandra R.
    Stennett, Andrea L.
    Dukhanin, Vadim
    Zwerling, Alice A.
    Merritt, Maria W.
    SSM-QUALITATIVE RESEARCH IN HEALTH, 2022, 2
  • [10] Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines
    Prabowo, Satria A.
    Groeschel, Matthias I.
    Schmidt, Ed D. L.
    Skrahina, Alena
    Mihaescu, Traian
    Hasturk, Serap
    Mitrofanov, Rotislav
    Pimkina, Edita
    Visontai, Ildik
    de Jong, Bouke
    Stanford, John L.
    Cardona, Pere-Joan
    Kaufmann, Stefan H. E.
    Werf, Tjip S. van der
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2013, 202 (02) : 95 - 104